About Psomagen, Inc.
As a CLIA-licensed research facility, we offer highly specialized sequencing services and utilize the latest next-gen sequencing. Psomagen employs highly trained researchers who are experts in their fields. Our next-generation sequencing services have been utilized by researchers from many prestigious institutions, including the National Institute of Health (NIH), the Food and Drug Administration (FDA), Stanford University, and many more.
Macrogen, Inc., the parent company, was founded in 1997, and in 2005, Macrogen Corp. was established in the U.S. In 2012, Macrogen Corp. was established to provide advanced clinical sequencing services to U.S. patients and hospitals. During this time, we’ve become a leading bioscience research firm and our reputation in the industry is proof of our commitment to advanced human genomic sequencing. In 2019, the name was changed so Psomagen, Inc. to better represent the vision of the company.